Loading insider details...
Beta
Latest Form 4 (Jun 9, 2026): Grant/Award of 30,000 CHRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 30,000 | n/a |
| Jun 5, 2026 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 59,701 | n/a |
| Jun 13, 2025 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 112,000 | n/a |
| Jun 6, 2025 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 49,796 | n/a |
| Jun 7, 2024 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 15,695 | n/a |
| Jun 5, 2024 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 112,000 | n/a |
| May 15, 2024 | MYRIAD GENETICS INC (MYGN) | Sale | 6,200 | $156.9K |
| Jun 9, 2023 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 38,250 | n/a |
| Jun 2, 2023 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 15,151 | n/a |
| Jun 3, 2022 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 17,275 | n/a |